title: The hypolipidaemic effect of EPA is potentiated by 2- and 3-methylation.
authors.affiliation: Department of Clinical Biochemistry, University of Bergen, Haukeland Hospital, Norway.
authors.forename: H
authors.initials: H
authors.lastname: Vaagenes
authors.forename: L
authors.initials: L
authors.lastname: Madsen
authors.forename: E
authors.initials: E
authors.lastname: Dyrøy
authors.forename: L
authors.initials: L
authors.lastname: Frøyland
authors.forename: N
authors.initials: N
authors.lastname: Willumsen
authors.forename: R K
authors.initials: RK
authors.lastname: Berge
mesh_terms: D042962:Acyl-CoA Oxidase; D000284:Administration, Oral; D000818:Animals; D002784:Cholesterol / Q000097:blood; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008745:Methylation; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism*; D010088:Oxidoreductases / Q000235:genetics / Q000378:metabolism; D010743:Phospholipids / Q000097:blood; D051381:Rats; D014280:Triglycerides / Q000097:blood
chemical_list: D000960:Hypolipidemic Agents; D008055:Lipids; D010743:Phospholipids; D014280:Triglycerides; D002784:Cholesterol; D015118:Eicosapentaenoic Acid; D010088:Oxidoreductases; D042962:Acyl-CoA Oxidase